| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 44.17▼ | 42.71▲ | 41.93▲ | N/A | N/A |
| MA10 | 43.58▼ | 41.34▲ | 40.71▲ | N/A | N/A |
| MA20 | 43.23▲ | 40.14▲ | N/A | N/A | N/A |
| MA50 | 41.24▲ | N/A | N/A | N/A | N/A |
| MA100 | 40.08▲ | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | N/A | N/A | N/A | N/A |
| RSI | 58.681▲ | 75.083▲ | N/A | N/A | N/A |
| STOCH | 89.785▲ | 86.315▲ | N/A | N/A | N/A |
| WILL %R | -43.265 | -17.506▲ | -13.086▲ | N/A | N/A |
| CCI | 50.005 | 145.990▲ | 168.515▲ | N/A | N/A |
| ▼ GAP | $MANE Open Gap Down %2 | Set Alert |
|
Monday, February 09, 2026 05:17 AM
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological ...
|
|
Thursday, February 05, 2026 01:05 PM
Veradermics, Incorporated ("Veradermics"), (NYSE: MANE) a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and ...
|
|
Thursday, February 05, 2026 02:30 AM
USA-based clinical-stage dermatology start-up Veradermics has announced the pricing of its upsized initial public offering of 15,077,647 shares of its common stock at an initial public offering price ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/02/26 | 40.45 | 44.78 | 38.58 | 44.04 | 236,825 |
| 10/02/26 | 36.50 | 42.00 | 36.50 | 40.45 | 443,249 |
| 09/02/26 | 37.91 | 38.79 | 36.255 | 37.03 | 414,959 |
|
|
||||
|
|
||||
|
|